The CCR is comprised of many NSU institutes and centers that focus on furthering knowledge and discovery in their respective areas of interest. Below are some examples of these institutes and centers.

NSU Institute for Neuro-Immune Medicine The NSU Institute for Neuro-Immune Medicine is a premier research and treatment center for chronic fatigue syndrome and other related neuro-immune disorders. The term neuro-immune disease refers to a group of illnesses that are the result of acquired dysregulation of both the immune system and the nervous system, often resulting in lifelong disease and disability. Symptoms may include mild to severe cognitive impairment; disordered sleep; severe headache; swollen lymph nodes; sore throat; malaise; postural orthostatic tachycardia; painful nerves, joints and or muscles; abdominal pain; nausea; and unusual fatigue. These diseases most often follow an infectious or flu-like illness that does not fully resolve after standard treatment or over a typical course of time. Diseases such as Human Immunodeficiency Virus (HIV/AIDs), fibromyalgia, autism spectrum disorder, Lyme disease and Gulf War Syndromes are some of the illnesses that are treated at the Institute.

Click here for more information.

Nova Southeastern University (NSU) is at the forefront of conducting pioneering biomedical research with the launch of its soon-to-be-completed, 215,000 sq. ft. Center for Collaborative Research (CCR), one of the largest and most advanced research facilities in Florida with state-of-the-art laboratories. The CCR will be home to a diverse group of accomplished physician-scientists and basic science researchers, representing many interdisciplinary sciences. As part of its bold new research mission, the university has launched the NSU Cell Therapy Institute, a unique collaboration with leading medical research scientists from Sweden’s world-renowned Karolinska Institutet (KI). KI is globally recognized for its Nobel Assembly, which awards the Nobel Prize in Physiology or Medicine annually.

NSU’s Rumbaugh-Goodwin Institute for Cancer Research The NSU Rumbaugh-Goodwin Institute for Cancer Research Inc. (RGI), a non-profit 501(c)(3) organization, was established in 1959. RGI merged with the Nova Southeastern University Health Professions Division in February 2005. Since the merger, RGI has been steadily expanding its programs and research activities. RGI is committed to rapidly developing anti-cancer therapies, in conjunction with industrial and academic partners, using efficient models of cancer growth and metastasis with the aim of moving novel compounds to market in the shortest time possible. Additionally, RGI is investigating 1) why cancer becomes resistant to chemotherapy over time, 2) how this resistance can be overcome, 3) which chemotherapeutic agents are most likely to work in an individual with particular genetic make-up and 4) what causes cancer to grow aggressively and spread. RGI’s main goal is to develop newer cancer therapies that can specifically target tumors, with minimal cellular damage and toxicity to the patient. Its long-standing relationships with the National Cancer Institute, National Institutes of Health, Royal Dames of Cancer Research Inc., American Cancer Society and other prominent organizations provide support for the advancement and development of these kinds of promising new investigational therapies.

NSU’s Emil Buehler Research Center for Engineering, Science and Mathematics

The NSU Emil Buehler Research Center for Science, Technology, Engineering and Mathematics is funded in part by a generous gift from the Emil Buehler Perpetual Trust. It will further the mission of the Emil Buehler Perpetual Trust through developing the skills that will support a sustainable pipeline and interest in science, technology, engineering and math related careers.

NSU’s Emil Buehler Research Center for Engineering, Science and Mathematics The NSU Technology Incubator will provide a range of supportive services to start-up companies including an entrepreneurial culture; office space; high-speed Internet connections; conference rooms; business services; mentoring; networking events; access to capital, patent, copyright and trademark counseling; secure 24-hour access; and a security lab.  The incubator will occupy 5,000 sq. ft. and house 10 to 12 small companies. Each company will have private, locked space and common facilities.  The incubator will utilize the Florida Lambda Rail high-speed fiber optic network to connect to the world at 10 GB/S and NSU’s supercomputer.